MA

Merrimack Pharmaceuticals

- NASDAQ:MACK
Last Updated 2024-04-23
  • Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

  • Locations

    • Memorial Drive, Cambridge 02142
    • 1 Kendall Sq Ste B7201, Cambridge MA
    • Cambridge MA

  • Total Funding (USD)

    77.0 million

  • Security

    Type: ORD
    CUSIP: 590328209
    ISIN: US5903282094
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo